« Back to Research Deepdives

Can (Poly)phenols Reduce Gut Symptoms in IBD and IBS?

This content is restricted to members.

To view our premium content, sign up for a membership:

Register New Account

Username

First Name

Last Name

Password

Password Again

Choose your membership level

Monthly Membership - €24.99 - 1 Month
Full Education Hub access: the weekly Study Deepdive, bi-monthly video Research Lectures, Exclusive Articles, and the full backcatalog of Deepdives in downloadable pdf format.
Annual Membership - €249.99 - 1 Year
Access to all the Education Hub content, at a reduced annual rate.

Discount Code - Valid - Invalid

Choose Your Payment Method

Credit / Debit Card PayPal

I agree to the privacy policy

‹ Back to Research Deepdives

References

1. Del Rio D, Rodriguez-Mateos A, Spencer J, Tognolini M, Borges G, Crozier A. Dietary (Poly)phenolics in Human Health: Structures, Bioavailability, and Evidence of Protective Effects Against Chronic Diseases. Antioxidants & Redox Signaling. 2013;18(14):1818-1892.
2. Rodriguez-Mateos A, Vauzour D, Krueger C, Shanmuganayagam D, Reed J, Calani L et al. Bioavailability, bioactivity and impact on health of dietary flavonoids and related compounds: an update. Archives of Toxicology. 2014;88(10):1803-1853.
3. Dryden G, Song M, McClain C. Polyphenols and gastrointestinal diseases. Current Opinion in Gastroenterology. 2006;22(2):165-170.
4. Tobias D, Wittenbecher C, Hu F. Grading nutrition evidence: where to go from here?. The American Journal of Clinical Nutrition. 2021;113(6):1385-1387.
5. Eysenck H. Meta-analysis or best-evidence synthesis?. Journal of Evaluation in Clinical Practice. 1995;1(1):29-36.
6. Eysenck H. Meta-analysis squared–does it make sense?. American Psychologist. 1995;50(2):110-111.
7. Mukherjee S, Dudley J, Das D. Dose-Dependency of Resveratrol in Providing Health Benefits. Dose-Response. 2010;8(4):dose-response.0.
8. Patel K, Scott E, Brown V, Gescher A, Steward W, Brown K. Clinical trials of resveratrol. Annals of the New York Academy of Sciences. 2011;1215(1):161-169.
9. Cai H, Scott E, Kholghi A, Andreadi C, Rufini A, Karmokar A et al. Cancer chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice. Science Translational Medicine. 2015;7(298):298ra117-298ra117.
10. Devkota S, Chang E. Interactions between Diet, Bile Acid Metabolism, Gut Microbiota, and Inflammatory Bowel Diseases. Digestive Diseases. 2015;33(3):351-356.
11. Ou J, Carbonero F, Zoetendal E, DeLany J, Wang M, Newton K et al. Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans. The American Journal of Clinical Nutrition. 2013;98(1):111-120.
12. Pittler M, Ernst E. Peppermint Oil for Irritable Bowel Syndrome: A Critical Review and Metaanalysis. American Journal of Gastroenterology. 1998;93(7):1131-1135.
13. Khanna R, MacDonald J, Levesque B. Peppermint Oil for the Treatment of Irritable Bowel Syndrome. Journal of Clinical Gastroenterology. 2014;48(6):505-512.
14. Young Hong M. Effects of Resveratrol on Inflammatory Bowel Disease: A Review. Journal of Nutritional Health & Food Science. 2014;2(3).